Showing results (371-380 of 895) with videos related to
Sort By:
Pageof 90
Drugs in R&D|November 8, 2008
Has molecular and cellular imaging enhanced drug discovery and drug development?Gang Niu, Xiaoyuan ChenDrugs in R&D|November 8, 2008
Dosage form proportionality and food effect of the final tablet formulation of eslicarbazepine acetate: randomized, open-label, crossover, single-centre study in healthy volunteersCarlos Fontes-Ribeiro, Tice Macedo, Teresa Nunes, et al.Drugs in R&D|June 29, 2007
Novel genetic techniques and approaches in the microbial genomics era: identification and/or validation of targets for the discovery of new antibacterial agentsMichael J PucciDrugs in R&D|June 29, 2007
Pharmacokinetics of darunavir (TMC114) and atazanavir during coadministration in HIV-negative, healthy volunteersVanitha J Sekar, Eric Lefebvre, Tine De Marez, et al.Drugs in R&D|September 14, 2022
Impact of Renal Function on Anti-factor Xa Activity Concentrations with Edoxaban Use in Patients with Non-valvular Atrial FibrillationRyohei Ono, Kazutaka Nishimura, Hidehisa Takahashi, et al.Drugs in R&D|November 20, 2023
Efficacy and Safety of Methylphenidate and Atomoxetine in Medication-Naive Children with Attention-Deficit Hyperactivity Disorder in a Real-World SettingYing Zhang, Li Yin, Cun You, et al.Drugs in R&D|March 18, 2024
Application of Transthoracic Echocardiography for Cardiac Safety Evaluation in the Clinical Development Process of Vaccines Against Streptococcus pyogenesUsman Nakakana, Alimamy Serry-Bangura, Bassey Effiom Edem, et al.Drugs in R&D|July 4, 2024
Comparative CNS Pharmacology of the Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib Versus Other BTK Inhibitor Candidates for Treating Multiple SclerosisTimothy J Turner, Pricilla Brun, Ross C Gruber, et al.Drugs in R&D|July 1, 2024
Antibody-Drug Conjugates in the Pipeline for Treatment of Melanoma: Target and Pharmacokinetic ConsiderationsIna Lami, Andrew J WiemerPageof 90